1. The clinical significance of Campylobacter pylori;Dooley, C.P.; Cohen, H.;Ann Intern Med,1988
2. Campylobacter pyloridis gastritis: the past, the present, and speculations about the future;Graham, D.Y.; Klein, P.D.,1987
3. Campylobacter pyloridis associated chronic active antral gastritis: A prospective study of its prevalence and the effects;Rauws, E.A.J.; Langenberg, W.; Houthoff, H.J.; Zanen, H.C.; Tytgat, G.N.J.
4. Production of peptides inducing chemotaxis and lysozomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo;Chadwick, V.S.; Mellor, D.M.; Myers, D.B.; Selden, A.C.; Keshavarzian, A.; Broom, M.F.;ScandJ Gastroenterol,1988
5. Purification and identification of formylmethionyl-leucyl-phenyl-alanine as a major peptide neutrophil chemo-tactic factor produced by;Marasco, W.A.; Phan, S.H.; Krutzsch, H.; Showell, H.J.; Feltner, D.E.; Nairn, R.;E coli. J Biol Chem,1984